Lv3
398 积分 2025-12-24 加入
Transarterial Chemoembolization Followed by Hepatic Arterial InfusionChemotherapy Combined a Tyrosine Kinase Inhibitor for Treatment ofLarge Hepatocellular Carcinoma
2个月前
已完结
Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial
2个月前
已完结
DEB-TACE-HAIC combined with donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma: a multicenter retrospective study
2个月前
已完结
Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in the Era of Systemic Therapies (2020–2025)
2个月前
已完结
Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial
3个月前
已完结
90Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial
6个月前
已完结
Chemotherapy for hepatocellular carcinoma: current status and future perspectives
6个月前
已完结
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
6个月前
已完结
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial
6个月前
已完结
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
6个月前
已完结
皖公网安备34019202002308
